Thomas Barnetche Selected Research

human MIRN433 microRNA

5/2010

A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Barnetche Research Topics

Disease

22	Rheumatoid Arthritis 01/2022 - 02/2006
7	Neoplasms (Cancer) 12/2021 - 04/2012
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2016
5	Psoriatic Arthritis 09/2021 - 02/2014
5	Necrosis 01/2019 - 09/2012
4	Rheumatic Diseases (Rheumatism) 06/2021 - 03/2017
2	Melanoma (Melanoma, Malignant) 12/2021 - 09/2012
2	Infections 12/2021 - 07/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2010
2	Disease Progression 11/2020 - 10/2017
2	Arthritis (Polyarthritis) 12/2019 - 12/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2018
2	Human Influenza (Influenza) 01/2016 - 07/2014
2	Inflammation (Inflammations) 12/2015 - 06/2012
2	Skin Neoplasms (Skin Cancer) 09/2012 - 04/2012
1	Spondylarthropathies 03/2022
1	Vitiligo 12/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 12/2021
1	Axial Spondyloarthritis 09/2021
1	Pain (Aches) 06/2021
1	digital ulcers 06/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Adult-Onset Still's Disease 12/2019
1	Heart Failure 01/2019
1	Morbid Obesity 01/2019
1	Avitaminosis (Vitamin Deficiency) 01/2019
1	Neonatal Systemic lupus erythematosus 12/2018
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2018
1	Ankylosing Spondylitis 10/2018
1	Ventricular Fibrillation 02/2018
1	Heart Block 02/2018
1	Pericardial Effusion 02/2018
1	Atrial Fibrillation 02/2018
1	Systemic Scleroderma (Systemic Sclerosis) 01/2018
1	Pruritus (Itching) 01/2018
1	Fatigue 01/2018
1	Obesity 12/2015
1	Knee Osteoarthritis 11/2015

Drug/Important Bio-Agent (IBA)

11	Biological ProductsIBA 09/2021 - 12/2010
10	Antirheumatic Agents (DMARD)IBA 12/2021 - 04/2012
6	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 06/2012
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021 - 01/2018
4	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2013
4	AntibodiesIBA 01/2018 - 09/2015
3	Rituximab (Mabthera)FDA Link 09/2021 - 07/2014
3	tocilizumab (atlizumab)FDA Link 03/2021 - 06/2012
3	Anti-Citrullinated Protein AntibodiesIBA 01/2018 - 03/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 09/2012
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2017
2	InterferonsIBA 01/2021 - 01/2016
2	AutoantibodiesIBA 01/2021 - 01/2018
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2016 - 07/2014
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2008 - 02/2006
1	GadoliniumIBA 03/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Galectins (Galectin)IBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 06/2021
1	Nucleic AcidsIBA 01/2021
1	SelectinsIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 11/2020
1	InflammasomesIBA 11/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	InterleukinsIBA 01/2019
1	Infliximab (Remicade)FDA Link 10/2018
1	CT-P13IBA 10/2018
1	Biosimilar PharmaceuticalsIBA 10/2018
1	apremilastIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Adalimumab (Humira)FDA Link 01/2018
1	Rheumatoid FactorIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	cyclic citrullinated peptideIBA 01/2018
1	Janus Kinase InhibitorsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	ImmunosorbentsIBA 12/2017
1	EnzymesIBA 12/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2017
1	B-Cell Activating FactorIBA 10/2017
1	Abatacept (Orencia)FDA Link 03/2016
1	Toll-Like Receptor 7IBA 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016
1	VaccinesIBA 01/2016
1	Interferon Type IIBA 01/2016
1	C-Reactive ProteinIBA 12/2015
1	ametantrone (HAQ)IBA 12/2015
1	6- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA 11/2015
1	SteroidsIBA 06/2015
1	Calcineurin InhibitorsIBA 06/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2015

Therapy/Procedure

9	Therapeutics 12/2021 - 05/2011
2	Biological Therapy 05/2020 - 01/2019
1	Injections 06/2021
1	Bariatric Surgery 01/2019
1	Stents 02/2018
1	Phototherapy (Light Therapy) 01/2018
1	Operative Surgical Procedures 07/2017